Compound Summary
Compound Name: | (+/-)-Vesamicol hydrochloride |
Compound CID: | 6603219 |
Synonyms: | (+/-)-Vesamicol hydrochloride Vesamicol hydrochloride, (+/-)- AH 5183 120447-62-3 L-(-)-Vesamicol hydrochloride More... |
Iupac Name: | (1R,2R)-2-(4-phenylpiperidin-1-yl)cyclohexan-1-ol;hydrochloride |
InChI: | InChI=1S/C17H25NO.ClH/c19-17-9-5-4-8-16(17)18-12-10-15(11-13-18)14-6-2-1-3-7-14;/h1-3,6-7,15-17,19H,4-5,8-13H2;1H/t16-,17-;/m1./s1 |
InChIKey: | XJNUHVMJVWOYCW-GBNZRNLASA-N |
Canonical Smiles: | C1CCC(C(C1)N2CCC(CC2)C3=CC=CC=C3)O.Cl |
Isomeric Smiles: | C1CC[C@H]([C@@H](C1)N2CCC(CC2)C3=CC=CC=C3)O.Cl |
Molecular Weight: | 295.8 |
Molecular Formula: | C17H26ClNO |
Molecular Weight: | 295.8 |
Molecular Formula: | C17H26ClNO |
Hydrogen Bond Donor Count: | 2 |
Hydrogen Bond Acceptor Count: | 2 |
Rotatable Bond Count: | 2 |
Heavy Atom Count: | 20 |
Complexity: | 266 |
(+/-)-Vesamicol hydrochloride | (+/-)-Vesamicol hydrochloride |
---|---|
(+/-)-Vesamicol hydrochloride |
Vesamicol hydrochloride, (+/-)- |
AH 5183 |
120447-62-3 |
L-(-)-Vesamicol hydrochloride |
AH-5183 hydrochloride |
Cyclohexanol, 2-(4-phenyl-1-piperidinyl)-, hydrochloride, trans-(+/-)- |
SMR000057879 |
SR-01000597931 |
UNII-N29SQS860M |
MLS000079837 |
MLS000758211 |
MLS001163935 |
MLS001423983 |
N29SQS860M |
CHEMBL1333097 |
AKOS024458596 |
CCG-100776 |
NC00026 |
NSC 759580 |
NCGC00180933-01 |
B6393 |
SR-01000597931-1 |
SR-01000597931-6 |
( inverted exclamation markA)-Vesamicol hydrochloride |
Q27284418 |
(+/-)-trans-2-(4-Phenylpiperidinyl)cyclohexanol hydrochloride |
(1R,2R)-2-(4-phenylpiperidin-1-yl)cyclohexanol hydrochloride |
(1R,2R)-2-(4-phenylpiperidin-1-yl)cyclohexan-1-ol;hydrochloride |
(1R,2R)-Cyclohexanol, 2-(4-phenyl-1-piperidinyl)-, hydrochloride |
Cyclohexanol, 2-(4-phenyl-1-piperidinyl)-, hydrochloride, trans- |
hydron;(1R,2R)-2-(4-phenylpiperidin-1-yl)cyclohexan-1-ol;chloride |
rel-(1R,2R)-2-(4-Phenylpiperidin-1-yl)cyclohexan-1-ol hydrochloride |
Cyclohexanol, 2-(4-phenyl-1-piperidinyl)-, hydrochloride (1:1), (1R,2R)-rel- |
1166453-59-3 |
Species | Dosage | Unit | CG Lifespan(AVG/MED days) | TG Lifespan(AVG/MED days) | Lifespan Change(AVG/MED%) | CG Lifespan(MAX days) | TG Lifespan(MAX days) | Lifespan Change(MAX%) | Significant | Strain | Gender | PubMed | Active Label |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Caenorhabditis elegans | 33 | umol/L | 16 | NS | N2 | 24134630 | Inactive |
Species | Lifespan Change(AVG/MED%) | Lifespan Change(MAX%) | Count Reference | Count Data point |
---|---|---|---|---|
Caenorhabditis elegans | 16 | 1 | 1 |